ES2040239T3 - Procedimiento de preparacion de una composicion farmaceutica para la profilaxis y terapia de la ulcera gastrica. - Google Patents

Procedimiento de preparacion de una composicion farmaceutica para la profilaxis y terapia de la ulcera gastrica.

Info

Publication number
ES2040239T3
ES2040239T3 ES198787119247T ES87119247T ES2040239T3 ES 2040239 T3 ES2040239 T3 ES 2040239T3 ES 198787119247 T ES198787119247 T ES 198787119247T ES 87119247 T ES87119247 T ES 87119247T ES 2040239 T3 ES2040239 T3 ES 2040239T3
Authority
ES
Spain
Prior art keywords
prophylaxis
therapy
pharmaceutical composition
preparation procedure
ulcera
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787119247T
Other languages
English (en)
Inventor
Giancarlo Farolfi
Giovanni Gazzani
Riccardo Niada
Marisa Mantovani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Crinos Industria Farmacobiologica SpA
Original Assignee
Crinos Industria Farmacobiologica SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crinos Industria Farmacobiologica SpA filed Critical Crinos Industria Farmacobiologica SpA
Application granted granted Critical
Publication of ES2040239T3 publication Critical patent/ES2040239T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA COMBINACION DE UN POLIMERO HIDROFILICO CON SULGLICOTIDO EN COMPOSICIONES FARMACEUTICAS PARA USO ORAL, MEJORA LA ACTIVIDAD ANTI-ULCERA DEL SULGLICOTIDO.
ES198787119247T 1987-01-12 1987-12-28 Procedimiento de preparacion de una composicion farmaceutica para la profilaxis y terapia de la ulcera gastrica. Expired - Lifetime ES2040239T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8719048A IT1215332B (it) 1987-01-12 1987-01-12 Composizione farmaceutica contenente sulglicotide per la terapia dell'ulcera gastrica

Publications (1)

Publication Number Publication Date
ES2040239T3 true ES2040239T3 (es) 1993-10-16

Family

ID=11154112

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787119247T Expired - Lifetime ES2040239T3 (es) 1987-01-12 1987-12-28 Procedimiento de preparacion de una composicion farmaceutica para la profilaxis y terapia de la ulcera gastrica.

Country Status (9)

Country Link
US (2) US4937079A (es)
EP (1) EP0274745B1 (es)
JP (1) JP2587441B2 (es)
AT (1) ATE69167T1 (es)
DE (1) DE3774415D1 (es)
ES (1) ES2040239T3 (es)
GR (1) GR3003555T3 (es)
IT (1) IT1215332B (es)
PT (1) PT86539B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1215332B (it) * 1987-01-12 1990-02-08 Crinos Industria Farmaco Composizione farmaceutica contenente sulglicotide per la terapia dell'ulcera gastrica
IT1230157B (it) * 1989-06-16 1991-10-14 Lisapharma Spa Uso di sucralfato gel umido per il trattamento di ulcere del derma e come veicolo di farmaci ad attivita' topica
US5102916A (en) * 1990-07-03 1992-04-07 Jacques Antoun Method of relieving gastric ulcers with carob extract
IT1246188B (it) * 1990-07-27 1994-11-16 Resa Farma Procedimento per la preparazione di composizioni farmaceutiche aventi aumentata velocita' di dissoluzione della sostanza attiva e composizioni ottenute.
US5232704A (en) * 1990-12-19 1993-08-03 G. D. Searle & Co. Sustained release, bilayer buoyant dosage form
WO1993019765A1 (en) * 1992-04-06 1993-10-14 Jacques Antoun Oak and carob bark composition for relieving gastric ulcers
ITMI20040989A1 (it) * 2004-05-18 2004-08-18 Gentium Spa Uso del sulglicotide per iul trattamento delle mucositi
KR100883999B1 (ko) * 2004-05-18 2009-02-17 젠티엄 에스피에이 점막염 치료를 위한 설글리코타이드의 용도
KR101088781B1 (ko) 2010-04-13 2011-12-01 삼일제약주식회사 설글리코타이드-함유 경구용 액상 제제
KR101088779B1 (ko) 2010-04-13 2011-12-01 삼일제약주식회사 설글리코타이드-함유 경구용 액상 제제
WO2015076294A1 (ja) * 2013-11-22 2015-05-28 キユーピー株式会社 薬剤の副作用である胃潰瘍の発症抑制方法、および胃潰瘍発症が抑制された経口薬剤組成物ならびにその製造方法
KR101819709B1 (ko) * 2017-01-13 2018-01-17 (주)아이엠디팜 설글리코타이드 또는 이의 약학적으로 허용가능한 염을 포함하는 안구건조증의 예방 또는 치료용 약학 조성물
KR102270073B1 (ko) * 2019-10-24 2021-06-28 삼일제약주식회사 설글리코타이드를 유효성분으로 포함하는 염증성 장질환의 예방 또는 치료용 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3522229A (en) * 1967-03-29 1970-07-28 Teikoku Hormone Mfg Co Ltd Glycoprotein from saliva or salivary glands having gastric acid secretion inhibitory as well as anti-ulcerative activity and method of collecting the same
GB1269987A (en) * 1968-04-18 1972-04-12 Garland Richard Brown Antacid composition
GB1249907A (en) * 1969-05-27 1971-10-13 Prephar Prospection De Rech S Process for the sulphonation of a glycopeptide
IT1061352B (it) * 1973-03-27 1983-02-28 Crinos Industria Farmaco Sali misti di esteri polisolforici di glicopeptidi naturali con metalli e con basi organiche e procedimento per la loro preparazione
US3961045A (en) * 1973-10-23 1976-06-01 National Starch And Chemical Corporation Method of treating ulcer
US4151276A (en) * 1975-05-12 1979-04-24 Armour Pharmaceutical Company Method of suppressing gastric acid secretion by the oral administration of calcitonin
IT1215332B (it) * 1987-01-12 1990-02-08 Crinos Industria Farmaco Composizione farmaceutica contenente sulglicotide per la terapia dell'ulcera gastrica

Also Published As

Publication number Publication date
DE3774415D1 (de) 1991-12-12
PT86539B (pt) 1991-12-31
US5085867A (en) 1992-02-04
ATE69167T1 (de) 1991-11-15
JP2587441B2 (ja) 1997-03-05
GR3003555T3 (es) 1993-03-16
IT1215332B (it) 1990-02-08
IT8719048A0 (it) 1987-01-12
EP0274745A1 (en) 1988-07-20
JPS63253029A (ja) 1988-10-20
PT86539A (en) 1988-02-01
EP0274745B1 (en) 1991-11-06
US4937079A (en) 1990-06-26

Similar Documents

Publication Publication Date Title
HK184896A (en) Pharmaceutical composition comprising loratadine ibuprofen and pseudoephedrine
LV5503A3 (lv) Panemiens omeprazola salu iegusanai
DE68919146D1 (de) Ausgewählte Stämme von Lactobacillus enthaltende pharmazeutische Zusammensetzungen.
ES2040239T3 (es) Procedimiento de preparacion de una composicion farmaceutica para la profilaxis y terapia de la ulcera gastrica.
DE3587974D1 (de) Orale hygienische Zusammenstellungen und ihrer aktiven Polymere.
ES2084579T3 (es) Uso de buspirona en la preparacion de una composicion farmaceutica para el tratamiento del abuso del alcohol.
IE873125L (en) Benzimidazole derivatives
ES542430A0 (es) Un procedimiento para la preparacion de una composicion antiacida de alginato de magnesio.
AU6788687A (en) A pharmaceutical which can be administered nasally, a process for its preparation, and its use
IT1229223B (it) Composizioni veterinarie sinergisticamente attive e procedimento per la loro preparazione.
IL79207A0 (en) Pharmaceutical compositions containing terguide
ATE82128T1 (de) Pharmazeutische zusammensetzungen zur behandlung von krebs.
AU7945787A (en) Use of anipamil
GB2185478B (en) Novel e-valerolactam, pharmacologically active compositions thereof, processes for the preparation thereof and their medical use
AU7111587A (en) Perhydrothiazepine and perhydroazepine derivatives,their preparation and their therapeutic use
FI890277A (fi) Tetrahydropyridinderivat.
IT8222494A0 (it) Derivati ad attivita'espettorante, procedimento per laloro preparazione e composizioni farmaceutiche che li contengono.
ES544593A0 (es) Un procedimiento para la preparacion de una composicion te- rapeutica de piretrinas, especialmente util en la profilaxisde la mixomatosis
IL85508A0 (en) Benzylaminoaryl-dihydropyridinelactones,their preparation and their use in medicaments
IT8420059A0 (it) Derivati del bis-mercapto - 1,10 decano, loro preparazione ed utilizzo in formulazioni farmaceutiche
MX11486A (es) Procedimiento para la preparacion de una composicion farmaceutica y composicion obtenida.
ZA843615B (en) 2-alkylthio-1-aminoalkyl-2-pyrroline-3-carbonitriles,processes for their preparation,as well as their use in the prophylaxis and therapy of thrombotic states
IT8648751A0 (it) 1-n-propil-3-(2-metil-butil)-7-(5idrossiesil)-8-alchil-xantine ad attivita' antibroncospastica,composizioni farmaceutiche che le contengono e relativo procedimento per laloro preparazione
IT8420333A0 (it) Derivati del bezafibrato, loro preparazione, e composizioni farmaceutiche che li contengono.
IT8420147A0 (it) Derivati del bezafibrato e procedimenti per la loro preparazione.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 274745

Country of ref document: ES